MADISON (WKOW) -- Wisconsin's two largest children's hospitals, American Family Children's Hospital and Children's Wisconsin, ...

FDA granted REVASCOR both Rare Pediatric Disease Designation (RPDD) and Orphan-Drug Designation (ODD) for congenital heart diseaseNEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq:MESO; ASX:MSB), ...

Background: The safety and efficacy of ibutilide in the cardioversion of atrial flutter and atrial fibrillation in children and in patients with congenital heart disease (CHD) is unknown.

Mesoblast’s Revascor gets US FDA’s regenerative medicine advanced therapy designation in children with congenital heart disease: New York Friday, December 6, 2024, 18:00 Hrs [ ...

Mesoblast Limited (MESO, MSB.AX) said that the U.S. Food and Drug Administration has granted its second generation allogeneic, ...

Madison’s UW Health Kids hospital and Milwaukee’s Children’s Wisconsin hospital announced they are collaborating to expand ...

Back to The Blalock-Taussig-Thomas Pediatric and Congenital Heart Center Main Menu If your child has been diagnosed with cardiomyopathy ... A hospital that is a recognized Center of Care provides high ...

When Nur Faathimah Assyifa’ turned two, she had surgery that involved switching the positions of two major arteries. Read ...

Expectant parents can now breathe a sigh of relief, thanks to advancements in fetal cardiology. Fetal echocardiograms, using ...

Mumbai: A 16-year-old girl from Baramati underwent a rare minimally invasive surgery for a congenital heart defect at Sir JJ ...